Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen Halasz

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Drug Development and Industrial Pharmacy|February 2, 2019
Nanodelivery of doxorubicin for age-related macular degenerationShannon J Kelly, Kathleen Halasz, Rudy Smalling, et al.
Assay and Drug Development Technologies|May 16, 2019
Micro/Nanoparticle Delivery Systems for Ocular DiseasesKathleen Halasz, Shannon J Kelly, Muhammad Tajwar Iqbal, et al.
Current Drug Delivery|October 19, 2018
Utilization of Apatinib-Loaded Nanoparticles for the Treatment of Ocular NeovascularizationKathleen Halasz, Shannon J Kelly, Muhammad Tajwar Iqbal, et al.
Canadian Journal of Physiology and Pharmacology|May 18, 2019
Nanoparticle drug delivery characterization for fluticasone propionate and in vitro testing <sup>1</sup>Vijaykumar Sutariya, Shannon J Kelly, Robert G Weigel, et al.
Biomedicines|September 14, 2018
Aflibercept Nanoformulation Inhibits VEGF Expression in Ocular In Vitro Model: A Preliminary ReportShannon J Kelly, Anjali Hirani, Vishal Shahidadpury, et al.
Canadian Journal of Physiology and Pharmacology|May 15, 2018
Nanodrug delivery platform for glucocorticoid use in skeletal muscle injuryVijaykumar Sutariya, Jared Tur, Shannon Kelly, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Drug Development and Industrial Pharmacy|February 2, 2019
Nanodelivery of doxorubicin for age-related macular degenerationShannon J Kelly, Kathleen Halasz, Rudy Smalling, et al.
Assay and Drug Development Technologies|May 16, 2019
Micro/Nanoparticle Delivery Systems for Ocular DiseasesKathleen Halasz, Shannon J Kelly, Muhammad Tajwar Iqbal, et al.
Current Drug Delivery|October 19, 2018
Utilization of Apatinib-Loaded Nanoparticles for the Treatment of Ocular NeovascularizationKathleen Halasz, Shannon J Kelly, Muhammad Tajwar Iqbal, et al.
Canadian Journal of Physiology and Pharmacology|May 18, 2019
Nanoparticle drug delivery characterization for fluticasone propionate and in vitro testing <sup>1</sup>Vijaykumar Sutariya, Shannon J Kelly, Robert G Weigel, et al.
Biomedicines|September 14, 2018
Aflibercept Nanoformulation Inhibits VEGF Expression in Ocular In Vitro Model: A Preliminary ReportShannon J Kelly, Anjali Hirani, Vishal Shahidadpury, et al.
Canadian Journal of Physiology and Pharmacology|May 15, 2018
Nanodrug delivery platform for glucocorticoid use in skeletal muscle injuryVijaykumar Sutariya, Jared Tur, Shannon Kelly, et al.
Pageof 1